CHCT

Community Healthcare Trust
CHCT

$16.22
0.49%

Market Cap: $449M

 

About: Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

Employees: 37

0
Funds holding %
of 6,686 funds
0
Analysts bullish %
of 6 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

563% more call options, than puts

Call options by funds: $4M | Put options by funds: $603K

18% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 56

0.58% less ownership

Funds ownership: 89.18% [Q1] → 88.6% (-0.58%) [Q2]

7% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 27

1% less funds holding

Funds holding: 170 [Q1] → 168 (-2) [Q2]

13% less capital invested

Capital invested by funds: $656M [Q1] → $569M (-$86.9M) [Q2]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$21
29%
upside
Avg. target
$25
54%
upside
High target
$30
85%
upside

6 analyst ratings

positive
33%
neutral
33%
negative
33%
Truist Securities
Michael Lewis
80% 1-year accuracy
28 / 35 met price target
36%upside
$22
Buy
Maintained
30 Aug 2024
Evercore ISI Group
Steve Sakwa
66% 1-year accuracy
31 / 47 met price target
29%upside
$21
Underperform
Maintained
28 Aug 2024
Evercore ISI Group
Steve Sakwa
66% 1-year accuracy
31 / 47 met price target
54%upside
$25
Underperform
Downgraded
31 Jul 2024
Baird
Amanda Sweitzer
0 / 0 met price target
54%upside
$25
Neutral
Maintained
31 Jul 2024
Evercore ISI Group
Steve Sakwa
66% 1-year accuracy
31 / 47 met price target
66%upside
$27
In-Line
Maintained
16 Jul 2024

Financial journalist opinion

Based on 3 articles about CHCT published over the past 30 days